아미쿠스 테라퓨틱스(Amicus Therapeutics)
US ˙ NasdaqGM ˙ US03152W1099
이 기호는 더 이상 활성화되지 않습니다.

SecurityFOLD / Amicus Therapeutics, Inc.
InstitutionRYDEX VARIABLE TRUST - Biotechnology Fund Variable Annuity
Latest Disclosed Ownership9,593 shares
Latest Disclosed Value $ 54,967
RYDEX VARIABLE TRUST - Biotechnology Fund Variable Annuity reports 18.26% increase in ownership of FOLD / Amicus Therapeutics, Inc.

On August 27, 2025 - RYDEX VARIABLE TRUST - Biotechnology Fund Variable Annuity filed a NPORT-P form disclosing ownership of 9,593 shares of Amicus Therapeutics, Inc. (US:FOLD) valued at $54,968 USD as of June 30, 2025. The entity filed a previous NPORT-P on May 29, 2025 disclosing 8,112 shares of Amicus Therapeutics, Inc.. This represents a change in shares of 18.26% during the quarter. The current value of the position is $139,003 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2025-08-27 2025-06-30 NP Amicus Therapeutics EC US03152W1099 9,593 1,481 18.26 55 -18.18 0.6109
2025-05-29 2025-03-31 NP Amicus Therapeutics EC US03152W1099 8,112 359 4.63 66 -9.59 0.7032
2025-03-03 2024-12-31 NP Amicus Therapeutics EC US03152W1099 7,753 -472 -5.74 73 -16.09 0.7322
2024-11-29 2024-09-30 NP Amicus Therapeutics EC US03152W1099 8,225 -233 -2.75 88 4.82 0.7956
2024-08-29 2024-06-30 NP Amicus Therapeutics EC US03152W1099 8,458 -739 -8.04 84 -23.15 0.7649
2024-05-30 2024-03-31 NP Amicus Therapeutics EC US03152W1099 9,197 234 2.61 108 -14.96 0.9188
2024-02-29 2023-12-31 NP Amicus Therapeutics EC US03152W1099 8,963 -661 -6.87 127 8.55 1.0424
2023-11-29 2023-09-30 NP Amicus Therapeutics EC US03152W1099 9,624 -112 -1.15 117 -4.10 1.0133
2023-08-28 2023-06-30 NP Amicus Therapeutics EC US03152W1099 9,736 -558 -5.42 122 7.02 0.9650
2023-05-30 2023-03-31 NP Amicus Therapeutics EC US03152W1099 10,294 -3,878 -27.36 114 -15.56 0.8647
2021-11-29 2021-09-30 NP Amicus Therapeutics EC US03152W1099 14,172 -1,149 -7.50 135 -8.16 0.5689
2021-08-27 2021-06-30 NP Amicus Therapeutics EC US03152W1099 15,321 -490 -3.10 148 -5.77 0.6186
2021-05-27 2021-03-31 NP Amicus Therapeutics EC US03152W1099 15,811 3,935 33.13 156 -43.07 0.7029
2021-03-01 2020-12-31 NP Amicus Therapeutics EC US03152W1099 11,876 11,876 274 1.1168
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.